Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: A study on-the-field

Journal of Endocrinological Investigation

Volumn 27, Issue 5, 2004, Pages 410-415

  Sartorio, A ^a   Marazzi, N ^a   Agosti, F ^a   Faglia, G ^a,c   Corradini, C ^c   De Palo, E ^b   Cella, S ^c   Rigamonti, A ^c   Muller, E E ^c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone turnover; Collagen synthesis; Elite athletes; GH

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; GROWTH HORMONE; ORAL CONTRACEPTIVE AGENT; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; AGE; ARTICLE; ATHLETE; BONE TURNOVER; COLLAGEN METABOLISM; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLING; FEMALE; HUMAN; ITALY; MALE; NORMAL HUMAN; RUNNING; SEX DIFFERENCE; SKIING; SPORT; STATISTICAL ANALYSIS; SWIMMING; TRAINING; VOLUNTEER; WALKING;

EID: 3242704003     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345283     Document Type: Article

References (12)

1. Daughaday WH. Growth hormone, insulin-like growth factors and acromegaly. In: DeGroot LJ ed. Endocrinology. 3rd ed. Philadelphia: W.B. Saunders Co. 1995, 303-9.
2. Johansen JS, Pedersen SA, Jorgensen JO, et al. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 1990, 70: 916-9.
3. Sartorio A, Conti A, Guzzaloni G, Faglia G. Serum osteocalcin levels in patients with GH deficiency before and during GH treatment. Acta Paediatr Scand 1991, 80: 100-2.
4. Sartorio A, Conti A, Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad Med J 1993, 69: 846-50.
5. Verde GG, Santi I, Chiodini P, Cozzi R, et al. Serum type III procollagen propeptide levels in acromegalic patients. J Clin Endocrinol Metab 1986, 63: 1406-10.
6. Salmela PI, Juustila H, Pyhtinen J, Jokinen K, Alavaiko M, Ruokonene A. Effective clinical response to long term octreotide treatment, with reduced serum concentrations of growth hormone, insulin-like growth factor-I, and the amino-terminal propeptide of type III procollagen in acromegaly. J Clin Endocrinol Metab 1990, 70: 1193-201.
7. Sartorio A, Monzani M, Conti A, Casati G, Faglia G. Serum amino-terminal propeptide of type III procollagen (PIIINP) levels in patients with acromegaly before and after pituitary adenomectomy. Eur J Intern Med 1993, 4: 79-83.
8. Longobardi S, Keay N, Ehrnborg C, et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2000, 85: 1505-12.
9. Brixen K, Nielsen HK, Mosekilde L, Flyvberg A. A short course of recombinant growth hormone stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 1990, 5: 609-18.
10. Sartorio A, Agosti F, Marazzi N, et al. Gender-, age-, body composition- and training workload-dependent differences of GH response to a discipline-specific training session in elite athletes: a study on the field. J Endocrinol Invest 2004, 27: 121-9
11. Ehrnborg C, Lange KHW, Dall R, et al. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 2003, 88: 394-401.
12. Wolthers OD, Heuck C, Heickendorff L. Diurnal variations in serum and urine markers of type I and type III collagen turnover in children. Clin Chem 2001, 47: 1721-2.